Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Allstate

Acuity Brands

First American Financial

Comfort Systems USA

Green Brick Partners

Ingles Markets

I've never seen the Old Faithful Geyser in Yellowstone National Park, but I'm grateful to it.

The Old Faithful Screen Has Lived Up to Its Name

Cigna has exhibited solid performance amidst a difficult economic backdrop.

3 Reasons Why Cigna Is An Undervalued Gem

Molina Healthcare

LONG BEACH, Calif. & BLOOMFIELD, Conn.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) and Cigna Corporation (NYSE: CI) today announced that they have entered into a definitive agreement pursuant to which Molina will acquire Cigna's Texas Medicaid and Medicare-Medicaid Plan (MMP) contracts and certain operating assets. As of December 31, 2020, Cigna's Texas Medicaid and MMP business served approximately 48,000 Medicaid members in the STAR+PLUS program in the Hidalgo, Tarrant, and Northeas

Molina Healthcare to Acquire Cigna's Texas Medicaid Contracts

BLOOMFIELD, Conn., April 22, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will present at the 2021 BofA Securities Health Care Conference on May 13, 2021 through a virtual webcast.

Cigna Corporation Announces Appearance at the 2021 BofA Securities Health Care Conference

BLOOMFIELD, Conn., April 22, 2021 /PRNewswire/ -- Cigna is introducing a broad range of new initiatives to encourage and expand access to COVID-19 vaccinations.

Cigna Introduces Broad Incentives to Encourage COVID-19 Vaccination

Oscar Health

BLOOMFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--Cigna (NYSE: CI), a global health service company, and Oscar Health, Inc. (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Cigna + Oscar1 small business health insurance will be available to Connecticut employers starting July 1, 2021. “Connecticut's small businesses need more choice and value in their health care coverage options, and that is what we will offer them and their employee

Cigna + Oscar Launches New Plans to Expand Affordable Coverage for Connecticut Small Businesses

Humana

Labcorp Holdings Inc

When screening the market for value opportunities, one method is to pick stocks whose trailing 12-month price-to-free cash flow ratios are low compared to that of the S&P 500 Index, which stands at around 13.18 currently.

A Trio of Health Care Stock Picks

BLOOMFIELD, Conn., April 15, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) will release its first quarter 2021 financial results on Friday, May 7, 2021, and will host a conference call the same day.

Cigna Corporation's First Quarter 2021 Earnings Release Details

Cincinnati Financial

Manulife Financial

Primerica

Unum

Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help Allstate, Cincinnati Financial, Manulife, Primerica, Cigna, Unum Group outperform Q1 earnings estimates.

6 Insurers Set to Outperform Estimates This Earnings Season

Cigna (CI) along with Oscar Health rolls out a health insurance product aimed for small business units in the state of California.

Cigna (CI), Oscar to Aid Small Business With Health Insurance

Goldman Sachs

Kinross Gold

They are all coming off great performances in 2020.

3 of the Best Value Stocks You Can Buy Right Now

British American Tobacco

If you are looking for high return investments, you could be interested in the three non-cyclical stocks listed below, as their earnings yields (as calculated via Joel Greenblatt (Trades, Portfolio)'s method) are beating the U.S. market.

3 High Return Non-Cyclical Stocks for the Value Investor

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” of the key U.S. life/health subsidiaries, health maintenance organizations and New Zealand- and Europe-based insurance companies of Cigna Corporation (Cigna) (headquartered in Bloomfield, CT) [NYSE: CI]. Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of “a” of Medco Containment Life Insurance

AM Best Affirms Credit Ratings of Cigna Corporation and Its Subsidiaries

AMN Healthcare Services

Centene

UnitedHealth Group

We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.

4 Stocks That Continue to Gain From Telehealth Offerings

As the S&P 500 hits record highs, some of its stocks have moved into overbought territory. Todd Gordon of TradingAnalysis.com says one could still have upside.

These five S&P 500 stocks have crossed into overbought territory, but one could still have upside

NASHVILLE, Tenn., March 16, 2021 /PRNewswire/ -- Global health service company Cigna (NYSE:CI) has named Robert Pettigrew president of its Medicare Advantage (MA) plans in Alabama, Mississippi and Northwest Florida.

Cigna Names Robert Pettigrew President of Medicare Advantage Plans in Alabama, Mississippi, Northwest Florida

NASHVILLE, Tenn., March 16, 2021 /PRNewswire/ -- Global health service company Cigna (NYSE:CI) has named Lisa Wagamon president of its Medicare Advantage (MA) plans in the Carolinas.

Cigna Names Lisa Wagamon President of Medicare Advantage Plans in the Carolinas

Hartford Financial Services Group

James River Group Holdings

MetLife

Old Republic International

Prudential Financial

7 Multiline Insurers to Watch Out For as COVID-Led Challenges Ease

The healthcare giant Cigna said during an investor day that it expected long-term adjusted earnings growth of 10% to 13% per share.

Why Analysts Are Raising Price Targets After Cigna's Investor Day

Cigna (CI) reported earnings 30 days ago. What's next for the stock?

Why Is Cigna (CI) Up 12.3% Since Last Earnings Report?

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned Long-Term Issue Credit Ratings of “bbb” to the $500 million .613% senior unsecured notes due 2024, $800 million 1.25% senior unsecured notes due 2026, $1.5 billion 2.375% senior unsecured notes due 2031 and $1.5 billion 3.4% senior unsecured notes due 2051 recently issued by Cigna Corporation (Cigna) (headquartered in Bloomfield, CT) [NYSE:CI]. The outlook assigned to these Credit Ratings (ratings) is stable. The existing ratings of Cigna and

AM Best Assigns Issue Credit Ratings to Cigna Corporation's New Senior Unsecured Notes

The stock price of Cigna, a health insurance and pharmacy services management company, is up 65% from the levels it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This compares with a 74% rise for S&P over the same period, with the resumption of.

Here's Why Cigna Stock Is Undervalued At $215

Cigna (CI) is set to buy MDLIVE, a provider of telehealth services, to gain share in the growing market.

Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout

Viatris

Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position boost in Cigna Corp. (NYSE:CI) and reductions in its holdings in Facebook Inc. (NASDAQ:FB), Quest Diagnostics Inc. (NYSE:DGX) and Alphabet Inc. (NASDAQ:GOOGL)(NASDAQ:GOOG).

Top 5 4th-Quarter Trades of Chris Davis' Firm

Citigroup

DuPont de Nemours

Deere & Company

Home Depot

Procter & Gamble

Visa

Micron Technology

When it comes to picking blue-chip stocks from the S&P 500, it's not just dividends that matter, and some names are being overlooked. The post 7 Blue-Chip Stocks to Buy Investors Are Overlooking appeared first on InvestorPlace.

News for Cigna Stock (CI)